• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

Eye check advised before starting T2 drug semaglutide

23/02/2023 No Comments

A small potential increased risk of retinopathy worsening after one year for those with Type 2 diabetes following injections of the GLP-1 agonist semaglutide does

Read More »

Novo Nordisk FDA submission for semaglutide

17/02/2017 No Comments

Novo Nordisk Novo Nordisk has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA)

Read More »

Follow us elsewhere

Facebook Twitter Instagram

Latest tweets

Recent posts

FDA approves cognitive-behavioural app for adults with Type 2 diabetes

Experts debate low-carb diets for people with diabetes

FDA approves cellular therapy for patients with Type 1 diabetes

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill